Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Tax Provisions (2016 - 2025)

Standard Biotools (LAB) has disclosed Tax Provisions for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 926.47% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $841000.0 through Dec 2025, up 50.99% year-over-year, with the annual reading at $892000.0 for FY2025, 64.58% up from the prior year.
  • Tax Provisions for Q4 2025 was $2.8 million at Standard Biotools, up from -$1.2 million in the prior quarter.
  • The five-year high for Tax Provisions was $2.8 million in Q4 2025, with the low at -$1.7 million in Q1 2021.
  • Average Tax Provisions over 5 years is -$230947.4, with a median of -$44000.0 recorded in 2023.
  • Peak annual rise in Tax Provisions hit 926.47% in 2025, while the deepest fall reached 1638.46% in 2025.
  • Over 5 years, Tax Provisions stood at -$1.4 million in 2021, then surged by 105.0% to $70000.0 in 2022, then plummeted by 162.86% to -$44000.0 in 2023, then surged by 718.18% to $272000.0 in 2024, then surged by 926.47% to $2.8 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $2.8 million, -$1.2 million, and -$600000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.